『Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in』（Lancet Oncol 2020;21:1213）より まとめ 未治療悪性胸膜中皮腫に対する…